Key points are not available for this paper at this time.
. These results suggest that PD-L1 on EVs may be another mechanism for glioblastoma to suppress antitumor immunity and support the potential of EVs as biomarkers in tumor patients.
Ricklefs et al. (Fri,) studied this question.